login
login

Europe Daily Bulletin No. 7728

31 May 2000
Contents Publication in full By article 52 / 53
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The American generic medicines manufacturer WATSON PHARMACEUTICALS will be paying at least USD 644 million for its competitor SCHEIN PHARMACEUTICALS. WATSON will be offering USD 19.50 for every SCHEIN share, in an attempt to acquire at least 75% in BAYER CORP.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION